UBS Maintains a 'Neutral' on InterMune (ITMN); Takeaways From Our Meeting on Pricing

August 15, 2012 11:53 AM EDT
Get Alerts ITMN Hot Sheet
Price: $73.89 --0%

Rating Summary:
    8 Buy, 9 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on InterMune Inc. (NASDAQ: ITMN) price target of $8.50 (from $10.50).

Analyst, Matthew Harrison, said, "At our recent meeting, management confirmed it still expects pricing/reimbursement in France, Italy and Spain before YE. In France, while we have the transparency committee’s recc. (ASMR 4, SMR 3), details such as pricing and the level of reimbursement remain unanswered. In Italy and Spain we have no visibility into the negotiations process and expect a press release from management as the first indication on pricing."

"Normally, we would expect a +5-10% move on each positive decision (e.g., the TC decision in France), but given the demand overhang for Esbriet (higher discontinuation rates in Germany), we would expect no more than a few % up."

For an analyst ratings summary and ratings history on InterMune Inc. click here. For more ratings news on InterMune Inc. click here.

Shares of InterMune Inc. closed at $8.00 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change

Related Entities

UBS